PATENT CLAIM ANALYSIS

Application Number: 15940133
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "235200"]

Abstract:
Described herein are quinoline compounds useful for, among other things, inhibition of the proteasome and for treatment of cancer and inflammation.

Claim (Index 15):
A compound of the formula: wherein: R 1 R 2 R 3 R 4 R 5 CH 3 H H H H H CH 3 H H H   H H H H   H CH 3 H CH 3   CH 3 H CH 3 H   CH 3 CH 3 H CH 3   CH 3 CH 3 H CH 3   CH 2 CH 3 CH 3 H CH 3   H CH 3 H CH 3   CH 2 CH 3 CH 3 H CH 3   CH 3 CH 3 H CH 3   CH 3 H CH 3   CH 3 H H H   H Cl H Cl   H Br H Br   CH 3 H Br H   CH 3 H Cl H   CH 3 H F H   CH 3 H CH 3 H   CH 3 H (CH 2 )CH 3 H   H H N(CH 3 ) 2 H   CH 3 H N(CH 3 ) 2 H   CH 2 CH 3 H N(CH 3 ) 2 H   CH 3 H H   CH 3 H H   CH 3 H OCH 3 H   CH 3 OCH 3 OCH 3 OCH 3   H H N(CH 3 ) 2 H   CH 3 H N(CH 3 ) 2 H   CH 3 H CH(CH 3 ) 2 H   H C(CH 3 ) 3 H N(CH 3 ) 2 H (CH 2 ) 3 CH 3 H H N(CH 3 ) 2 H CH 2 CH 3 CH 2 CH 3 H N(CH 3 ) 2 H   CH 3 H N(CH 3 ) 2 H   H N(CH 3 ) 2 H   CH 3 H (CH 2 ) 3 CH 3 H   CH 3 H (CH 2 ) 3 CH 3 H   CH 3 H Br H   CH 3 H CH(CH 3 ) 2 H   CH 3 H (CH 2 ) 3 CH 3 H   CH 3 CH 3 CH 3 CH 3 .

Metadata:
- Claim Count in Document: 24.0
- Percentile: 90.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12950764', '13262888', '14658736', '14431935', '13821195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7594710964263632
- 35 USC 102 Novelty (BERT): 0.5025996851346324
- Combined Prediction Score: 0.7337839552971902
- Mean Citation Score: 195.95137800000003
- Max Citation Score: 197.04544
- Similarity Product: 120.40863475837708

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test